Husam Ansari
Novartis (Switzerland) · Carl Zeiss (Germany) · AbbVie (United States)
In this database
3
2020 – 2025
DB Citations
32
across indexed articles
h-index
12
OpenAlex (all works)
Total Citations
1,054
OpenAlex (all works)
3 articles in Glaucoma Journal Club
Clinical Outcomes of Ahmed ClearPath Implantation in Glaucomatous Eyes: A Novel Valveless Glaucoma Drainage Device.
The new ACP appears to be safe and efficacious as a standalone procedure or in combination with other procedures for uncontrolled glaucoma, and may be considered as a GDD option for patients in whom its…
Incidence and Outcome of Uveitic Glaucoma in Eyes With Intermediate, Posterior, or Panuveitis Followed up to 10 Years After Randomization to Fluocinolone Acetonide Implant or Systemic Therapy.
The implant has substantially higher risk of glaucoma than systemic therapy, a difference not entirely explained by posttreatment IOP elevation.
One-Year Real-World Outcomes of Ab-Externo Gel Stent Placement From the EXPAND Study.
Ab-externo GS placement effectively lowered IOP and the medication count without unexpected complications/AEs, expanding implantation options based on patients' needs and surgeons' preferences.